Aviso: Este sitio agrega datos públicos oficiales de la FDA, ClinicalTrials.gov, PubMed y SEC EDGAR solo como referencia general. No constituye asesoramiento médico, diagnóstico, recomendaciones de tratamiento ni asesoramiento de inversión.

PMA de la FDA

KIT, TEST, ALPHA-FETOPROTEIN FOR NEURAL TUBE DEFECTS

Número de PMA: P970037 · 2021-08-11

SolicitanteRevvity, Inc.
Fecha de decisión2021-08-11
Número PMAP970037
Código de productoLOK
Clase del dispositivoClase 3
Especialidad médicaU
Comité asesorIM

Resumen del dispositivo

KIT, TEST, ALPHA-FETOPROTEIN FOR NEURAL TUBE DEFECTS is the device name listed in this FDA 510(k) record. The listed applicant is Revvity, Inc.. It received FDA 510(k) clearance on 2021-08-11. The device is classified under product code LOK. It was reviewed by the IM advisory panel.

Preguntas frecuentes

What is the KIT, TEST, ALPHA-FETOPROTEIN FOR NEURAL TUBE DEFECTS?

KIT, TEST, ALPHA-FETOPROTEIN FOR NEURAL TUBE DEFECTS is a medical device that received FDA 510(k) clearance on 2021-08-11. The listed applicant is Revvity, Inc..

When did KIT, TEST, ALPHA-FETOPROTEIN FOR NEURAL TUBE DEFECTS receive FDA 510(k) clearance?

The clearance date for KIT, TEST, ALPHA-FETOPROTEIN FOR NEURAL TUBE DEFECTS can be found in the official FDA records.

Who is the listed applicant for KIT, TEST, ALPHA-FETOPROTEIN FOR NEURAL TUBE DEFECTS?

The FDA 510(k) record lists Revvity, Inc. as the applicant. This does not by itself establish the device manufacturer.

What is the FDA product code for KIT, TEST, ALPHA-FETOPROTEIN FOR NEURAL TUBE DEFECTS?

The FDA product code for KIT, TEST, ALPHA-FETOPROTEIN FOR NEURAL TUBE DEFECTS is LOK.

Ensayos clínicos relacionados

Los registros relacionados se emparejan automáticamente mediante nombres, códigos de producto u otros metadatos. Un emparejamiento no establece una relación clínica, científica, corporativa o regulatoria verificada; revise las fuentes oficiales enlazadas.

NCT07608549FLASH Pilot Phase 1 Safety StudyNOT_YET_RECRUITINGNCT06562205PAP Systems External Clinical Studies (ECS)NOT_YET_RECRUITINGNCT06443177The Effect of Sympathetic Modulation on Cerebral Vasospasm Secondary to Aneurysmal Subarachnoid HemorrhageSUSPENDEDNCT07095751Artificial Intelligence-assisted Uro-Cam Catheter Assessment System for Diagnosing Bladder CancerNOT_YET_RECRUITING

Fuente oficial

Ver en la base de datos de la FDA →

Datos procedentes de la API abierta de la FDA. Para obtener la información más actualizada y autoritativa, consulte siempre el registro oficial.

↑